The role of 131I in the treatment and management of thyroid cancer
Current Radiopharmaceuticals · 2026-01 · 19 (1) · 100009
DOI: 10.1016/j.craph.2025.100009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Radiopharmaceuticals, 2026-01. Verfasst von Juhi Rais und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Council of Scientific and Industrial Research, India
Zitieren
APA
Rais, J., Gambhir, S., & Dixit, M. (2026). The role of 131I in the treatment and management of thyroid cancer. Current Radiopharmaceuticals, 19(1), 100009. https://doi.org/10.1016/j.craph.2025.100009
Vancouver
Rais J, Gambhir S, Dixit M. The role of 131I in the treatment and management of thyroid cancer. Current Radiopharmaceuticals. 2026;19(1):100009. doi:10.1016/j.craph.2025.100009
BibTeX
@article{Rais2026,
author = {Rais, Juhi and Gambhir, Sanjay and Dixit, Manish},
title = {The role of 131I in the treatment and management of thyroid cancer},
journal = {Current Radiopharmaceuticals},
year = {2026},
volume = {19},
number = {1},
pages = {100009},
doi = {10.1016/j.craph.2025.100009}
}
EUVIMED